Navigation Links
NightHawk Radiology exclusive radiology provider for high-risk plaque research initiative
Date:1/30/2008

COEUR DALENE, Idaho, January 30, 2008 Preventative heart healthcare gains strong momentum today as NightHawk Radiology Holdings, Inc. (Nasdaq: NHWK), announced its involvement as the exclusive radiology provider for the High-Risk Plaque Initiative (HRP Initiative). The HRP Initiative is a joint research effort to advance the understanding and management of high-risk plaque, which is believed to be the primary underlying cause of heart attacks and strokes.

As part of the research effort, NightHawks U.S. Board Certified radiologists will interpret Chest CT scans for approximately 6,000 study participants. Additionally, NightHawk Radiology Services expects its affiliated radiologists will read approximately 1,000 Cardiac CTA scans performed on a subset of participants believed to be at higher risk for a cardiac event. Cardiac CTA is a heart-imaging test that is rapidly gaining acceptance for its ability to non-invasively determine whether fatty or calcium deposits (i.e., plaque) have built up in the coronary arteries. The purpose of the interpretation of the CT Chest scans by NightHawks affiliated radiologists is to identify clinically significant cardiac and non-cardiac findings where the participant might benefit from its detection and follow-up.

Since there are currently no non-invasive methods of screening, diagnosis, or treatment for high-risk plaque, the HRP Initiatives goal is to provide a roadmap for the development of screening, diagnostic, and therapeutic interventions for high-risk plaque, and promote proper use to patients, providers and payors.

NightHawk was chosen because it was the single teleradiology provider with the strategic experience managing the complex technical aspects and reporting requirements of CCTA reconstructions, said Cherrill Farnsworth, President and Chief Executive Officer of HealthHelp, a radiology benefit management company that is coordinating the teleradiology aspect of the HRP Initiative. NightHawks resources, flexibility, and expertise place them at the forefront of CCTA and the 3D reconstruction. They are the only global provider with a viable solution that is available today.

NightHawk Radiology Services has deployed an independent imaging network solution explicitly for the HRP Initiative and it expects to begin evaluating reads in the first quarter of 2008.

We are very excited to be a part of this initiative, which involves high-profile medical institutions, leading pharmaceutical and medical technology companies, and scientists in the fields of cardiology, pathology, and imaging, said Dr. Paul Berger, Chairman and Chief Executive Officer of NightHawk Radiology Services. Participating in this initiative builds on the opportunities that lie ahead for our new service offerings such as CCTA, which we believe will continue to gain acceptance as the standard non-invasive diagnostic tool.


'/>"/>

Contact: Robert Minicucci
robert@warnerpr.com
603-488-5856
Warner Communications
Source:Eurekalert

Related medicine news :

1. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
2. NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
3. NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007
4. NightHawk Radiology: One Source, One Solution
5. NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008
6. NightHawk Radiology Holdings, Inc. Announces Preliminary 2007 Results
7. NightHawk Radiology Holdings, Inc. Announces Date for Fourth Quarter and Full-Year 2007 Earnings Conference Call
8. AIUM CEO named among most influential in radiology
9. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
10. Franklin & Seidelmann Enters Full-Service Teleradiology Market with Acquisition of Apex Radiology
11. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Sharon Kleyne, host of the nationally syndicated radio ... on Voice of America, declared on her radio program in November 2016 the need ... when these bullies attack leaders in corporate America, they are trying to take advantage ...
(Date:12/7/2016)... ... December 07, 2016 , ... 1105 Media’s Live ... the Folio: Marketing Awards competition. Live From won in the Use of Social ... and ultimately successful projects undertaken by the media industry’s most innovative marketing professionals. ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., a ... Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with ... help patients realize their family building goals. Acupuncture helps fertility patients ...
(Date:12/7/2016)... NORFOLK, Va. (Dec. 3, 2016) , ... (PRWEB) ... ... the nation’s only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, ... work in New Mexico with a patient engagement program. New Mexico has more ...
(Date:12/6/2016)... ... December 06, 2016 , ... People ... can be seen on a type of MRI, according to a study appearing ... of the central nervous system characterized by tremors or trembling and stiffness in ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016   AlloSource , one ... bone, skin and soft-tissue allografts for use in ... Process Manager, for being named to the Board ... Quality Award by the Commerce Department,s National Institute ... commitment to process excellence. The Baldrige Award is ...
(Date:12/6/2016)... , Dec. 6, 2016   ... clinical-stage medical dermatology and aesthetics company, today ... privately held specialty pharmaceutical company focused on ... skin conditions, including psoriasis, atopic dermatitis and ... agreement, Sienna will make an undisclosed upfront ...
(Date:12/6/2016)... 6, 2016  Blueprint Medicines Corporation (NASDAQ: ... kinase medicines for patients with genomically defined diseases, today ... of $125,000,000 million in shares of its common stock. ... a 30-day option to purchase up to an additional ... in connection with the public offering. All shares of ...
Breaking Medicine Technology: